Pembrolizumab as the first-line monotherapy for...

  • Main
  • 2020 / 1
  • Pembrolizumab as the first-line monotherapy for...

Pembrolizumab as the first-line monotherapy for non-small-cell lung cancer with a low programmed death ligand 1 threshold

Xu, Zhijie, Wang, Xiang, Chen, Xi, Zeng, Shuangshuang, Gong, Zhicheng, Yan, Yuanliang
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Cell Communication and Signaling
DOI:
10.1007/s12079-020-00547-6
Date:
January, 2020
File:
PDF, 165 KB
english, 2020
Conversion to is in progress
Conversion to is failed